BioPatent Design2010

Building a Robust, Secure Biological Patent to Ensure First Time Approval, Protect Product Revenue and Prevent Incoming Attack

The area of BioPatent Design is rapidly evolving, with new developments sparking the Gene debate, developments in Biosimilars, protection issues with regards to DNA sequencing patents, vaccines and stem cells as well as new guidelines issued from the EPO. This is a critical time to make the correct patent drafting decisions! Pharma IQ’s BioPatent Design offers you the perfect gathering to find your solutions.

Who will be speaking at BioPatent Design 2010?

When: 07 – 09 September, 2010

Where: Maritim Hotel, Munich, Germany

Email: enquire@iqpc.co.uk

Visit: www.biopatentdesign.com

  Print This Post Print This Post  

One Comment

  1. Notice: Object of class WP_Comment could not be converted to int in /hermes/bosnacweb01/bosnacweb01ad/b2262/ipw.patentba/public_html/wp/wp-content/plugins/polldaddy/rating.php on line 7

    […] IP piece o' the day: BioPatent Design Conference 2010: Munich, Germany by Stephen Albainy-Jenei at […]